---
$id: https://graph.org.ai/products/commodity/51381907
$type: Product
source: UNSPSC
code: "51381907"
title: "Oxolamine citrate"
class: "51381900"
classTitle: "Nonsteroidal anti inflammatory azoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxolamine citrate

**UNSPSC Code**: 51381907
**Class**: [Nonsteroidal anti inflammatory azoles](Nonsteroidal anti inflammatory azoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C14H19N3O.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K5X4XBR694, chemically known as 1,2,4-oxadiazole, 5-(2-(diethylamino)ethyl)-3-phenyl-, citrate but more generally known as oxolamine citrate, which bears US NIH Compound Identifier 16045. European Medicines Agency schedules Oxolamine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03576MIG. Most nations, for tariff and trade purposes, schedule oxolamine citrate under HS 29349990 and SITC 51579. As of Q4 2014, OXOLAMINE CITRATE remains US FDA's Preferred Term for this commodity. SMILES: CCN(CC)CCC1NC(NO1)C2CCCCC2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

